In the news | 16th May 2022
Want to avoid biotech's newest bottleneck? Design your digital strategy early on.
In the quest to develop the science and raise funding, developing a digital strategy in general is an afterthought for fledgling biotech companies – if it’s considered at all. Not paying attention to it early, however, can hamper their ability to advance their science and constrain their revenue-generation options.
Read more in this article featuring Matt Clifford, IDBS, published in BioSpace.
New process definition capabilities in PIMS further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers
New process definition capabilities in PIMS 5.1, further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers.
Tradeshow | European BioAnalysis Forum | Nov 2023
Come and see us at Festival of Biologics in Basel. Visit our booth 604 and hear Marc Smith, Director of Strategic Solutions, speak.
Software validation keeps GxP systems current and speeds up time-to-market
Requirements to maintain a GxP environment means researchers must conduct software validation on any updated software so it continues to meet users’ needs.
Tradeshow | Cell UK 2023 London | November, 2023
Talk on “Streamlining upstream development: an integrated digital backbone to combine product and process insight for a more efficient path to success.”